中安科: 关于回购注销部分限制性股票的公告

Core Viewpoint - The company has decided to repurchase and cancel a total of 3,481,750 restricted shares at a repurchase price of 1.25 yuan per share, following the authorization from the shareholders' meeting and the board's approval [1][11][12] Summary by Sections Stock Repurchase and Cancellation - The number of restricted shares to be repurchased and canceled is 3,481,750 shares [1] - The repurchase price is set at the grant price of 1.25 yuan per share [11] - The decision to implement this repurchase was authorized by the shareholders' meeting held on April 3, 2023 [1][12] Approval Process and Implementation Progress - The company held its first temporary shareholders' meeting in 2023, where the proposal for the stock incentive plan was approved [2] - The independent directors expressed clear agreement on the proposal, and legal opinions were provided [2] - The company conducted a self-examination regarding insider trading prior to the announcement of the incentive plan and found no violations [2] Impact on Share Capital Structure - Following the repurchase and cancellation, the total number of shares will decrease from 2,876,607,560 to 2,866,180,886 shares [11] - The repurchase will not have a substantial impact on the company's financial status or operational results [11][12] Future Work Arrangements - The company will follow legal procedures for capital reduction, including notifying creditors and updating company registration [12] - The remuneration and assessment committee has agreed that the repurchase complies with relevant laws and regulations [12] Legal Opinions - The legal opinion confirms that the repurchase has obtained necessary approvals and adheres to relevant regulations, ensuring no adverse effects on the company's management or financial condition [12]